You’ve probably never heard of intrathecal care. It’s a new drug-delivery method used by palliative care specialists in which a catheter is inserted near the spinal cord, similar to an epidural. It enables pain relief while allowing mobility and lucidity.
This kind of medical advance changes the game on end-of-life care.
The Australian Medical Association estimates it would cost about an extra $275 million a year to make quality supportive care available to all terminally ill Australians who need it. It’s expensive, but certainly possible. It’s a choice that a progressive government could and should make.
Cancer patients are testing a drug made from antibodies designed from the ground up on a computer in Israel and “programmed” by the inventor to “decide” whether cells surrounding tumors are good or bad. If the study underway in Australia goes according to plan, these antibodies will target cells that help the tumor while boosting the abilities of cells that inhibit cancer growth. Their inventor, Prof. Yanay Ofran, said that antibody treatments have traditionally been based on human or animal antibodies... making antibodies from scratch on a computer and then making them from amino acids removes previous limitations... https://israeltrade.org.au/2022/11/23/australian-cancer-patients-te
The recipe for mammalian life is simple: take an egg, add sperm and wait. But two new papers demonstrate that there’s another way. Under the right conditions, stem cells can divide and self-organize into an embryo. In studies published in Cell and Nature recently, two groups report that they have grown synthetic mouse embryos for 8.5 days, longer than ever before. The embryos developed distinct organs — a beating heart, a gut tube and even neural folds.Research is being conducted at University of Cambridge, UK, and the California Institute of Technology in Pasadena. For more information: https://www.nature.com/articles/d41586-022-02334-2